+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-11-16Number of Pages: 80

Autoimmune Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Global Autoimmune Disease Diagnostics Market Insights 

As autoimmune diseases grip millions around the world, the research and development of novel therapeutics and diagnostics is gaining momentum. With the incidence of autoimmune diseases rapidly increasing around the world, efficient autoimmune disease diagnostics is now considered indispensable.

Compelled by these factors, governments around the world have considerably increased their healthcare spending. The research and development of novel diagnostics has also paced up in the last few years to prevent the spread autoimmune diseases. TMR forecasts that the global autoimmune diseases diagnostics market will expand at a steady CAGR of 3.8% between 2015 and 2023. During the course of the forecast period, price competitiveness among key players will however have an adverse impact on the market’s trajectory.

Nevertheless, with multinational companies capitalizing on opportunities across emerging economies, TMR projects the global autoimmune disease diagnostics market to reach US$17.06 bn by 2023. The market was valued at US$12.3 bn in 2014.

High Awareness about Medical Procedures Puts North America in Dominant Position

Regionally, North America emerged dominant in the global autoimmune disease diagnostics market in 2014, with a share of 39%. In North America, the U.S. and Canada have presently emerged as the most lucrative markets for autoimmune disease diagnostics. Both these countries boast sophisticated healthcare infrastructure with advanced laboratory techniques, and significantly high awareness about various medical procedures. The overall high healthcare expenditure across the region, also puts North America at the fore in the global autoimmune disease diagnostics market.

According to TMR, the North America autoimmune disease diagnostics market at US$4.8 bn in 2014. Rising at a CAGR of 3.7%, the market is expected to reach US$6.6 bn by the end of 2023.

However, Asia Pacific is forecast to emerge as the fastest growing regional market for autoimmune disease diagnostics. The rising demand from countries such as India, Australia, Japan, China, Malaysia, and other emerging nations will bolster opportunities for the market in Asia Pacific. Furthermore, the advances of diagnostic techniques witnessed in Asia Pacific, adoption of sophisticated technologies, and favorable government support will boost the autoimmune disease diagnostics market in the region. As per TMR, the Asia Pacific market will exhibit a CAGR of 4.3% during the course of the forecast period.

High Prevalence of Rheumatoid Arthritis Fuels Demand for Efficient Autoimmune Disease Diagnostics

The most common autoimmune diseases include Graves’ disease, multiple sclerosis, Hashimoto’s thyroiditis, rheumatoid arthritis, type1 diabetes, and systemic lupus erythematosus. Of these, the prevalence of rheumatoid arthritis is the highest since it can occur at any age. Rheumatoid arthritis has therefore emerged as the largest segment in the autoimmune disease diagnostics market, based on disease type. The segment stood at US$3.2 bn in 2014. Rising at a CAGR of 4.2%, it is expected to reach US$4.6 bn by the end of 2022.

The incidence of rheumatoid arthritis is expected to rise in the forthcoming years due to the increasing geriatric population. The segment will also gain from the improved laboratory arrangements for the diagnosis of rheumatoid arthritis. Besides this, the prevalence of type 1 diabetes has been rising globally, which also augments the demand for efficient autoimmune disease diagnostics. TMR expects the type 1 diabetes segment to surge at a CAGR of 3.7% between 2015 and 2023.

Some of the leading companies operating in the global autoimmune disease diagnostics market are Siemens Healthcare, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., and Abbott Laboratories.


1. Preface
     1.1. Report Description
     1.2. Market Segmentation
     1.3. Research Methodology

2. Executive Summary
     2.1. Autoimmune Disease Diagnostics: Market Snapshot
     2.2. Global Autoimmune Disease Diagnostics Market, by Test Type, 2014 (US$ Mn)
     2.3. Global Autoimmune Disease Diagnostics Market Share, by Geography, 2014–2023 (US$ Mn)

3. Global Autoimmune Disease Diagnostics Market – Industry Analysis
     3.1. Introduction
     3.2. Drivers
           3.2.1. High Prevalence of Autoimmune Diseases Across the World
           3.2.2. Increased Health Care Expenditure Globally
           3.2.3. Growing Awareness Among People About Autoimmune Diseases
     3.3. Restraints
           3.3.1. Competitive Pricing and Equipment Costs
           3.3.2. Shortage of Skilled Labor
     3.4. Opportunities
           3.4.1. Emerging Economies to Offer Sustained Growth Opportunities
           3.4.2. New products, Services, and Device Development
     3.5. Porter’s Five Forces Analysis 
     3.6. Market Attractiveness Analysis– Autoimmune Disease Diagnostics Market, by Geography, 2014 (%) 
     3.7. Competitive Landscape – Autoimmune Disease Diagnostics Market, by Key Players, 2014 (%)

4.  Market Segmentation – By Test Type
     4.1. Introduction
     4.2. Global Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
     4.3. Global Antinuclear Antibody Test Market Revenue, 2013–2023 (US$ Mn)
     4.4. Global Autoantibody Test Market Revenue, 2013–2023 (US$ Mn)
     4.5. Global Complete Blood Count Market Revenue, 2013–2023 (US$ Mn)
     4.6. Global Comprehensive Metabolic Panel Market Revenue, 2013–2023 (US$ Mn)
     4.7. Global C-reactive Protein Market Revenue, 2013–2023 (US$ Mn)
     4.8. Global Erythrocyte Sedimentation Rate Market Revenue, 2013–2023 (US$ Mn)
     4.9. Global Urinalysis Market Revenue, 2013–2023 (US$ Mn)
     4.10. Global Other Tests Market Revenue, 2013–2023 (US$ Mn)

5. Market Segmentation – By Disease Type
     5.1. Introduction
     5.2. Global Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
     5.3. Global Graves’ Disease Market Revenue, 2013–2023 (US$ Mn)
     5.4. Global Hashimoto’s Thyroiditis Market Revenue, 2013–2023 (US$ Mn)
     5.5. Global Multiple Sclerosis Market Revenue, 2013–2023 (US$ Mn)
     5.6. Global Rheumatoid Arthritis Market Revenue, 2013–2023 (US$ Mn)
     5.7. Global Systemic Lupus Erythematosus Market Revenue, 2013–2023 (US$ Mn)
     5.8. Global Type 1 Diabetes Market Revenue, 2013–2023 (US$ Mn)
     5.9. Global Other Diseases Market Revenue, 2013–2023 (US$ Mn)

6. Autoimmune Disease Diagnostics Market - Regional Analysis
     6.1. Introduction
     6.2. Global Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
     6.3. North America Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
     6.4. Europe Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
     6.5. Asia Pacific Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
     6.6. RoW Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)

7. Recommendations

8. Company Profiles
     8.1. Abbott Laboratories, Inc.
     8.2. Beckman Coulter, Inc. 
     8.3. bioMérieux SA 
     8.4. Bio-Rad Laboratories 
     8.5. F.Hoffmann-La Roche Ltd.
     8.6. Inova Diagnostics, Inc.
     8.7. Quest Diagnostics 
     8.8. SQI Diagnostics, Inc. 
     8.9. Siemens Healthcare

This report on the autoimmune disease diagnostics market studies the current and future prospects of the global market. Autoimmune disease diagnostics market includes various laboratory tests that are performed to diagnose autoimmune disorders. These tests include blood tests for one or more autoantibodies and tests for inflammation. The rising prevalence of autoimmune diseases, increase in health care expenditure globally, rising government initiatives and increasing automation in laboratories leading to higher sensitivity, faster and easy performance will drive the market of autoimmune disease diagnostics. The autoimmune disease diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global autoimmune disease diagnostics market with respect to market segments based on the test type and diseases and their geographic analysis.

Based on test type, the autoimmune disease diagnostics market has been segmented into eight major categories: antinuclear antibody test, autoantibody test, complete blood count, comprehensive metabolic panel, C-reactive protein test, erythrocyte sedimentation rate, urinalysis and others. On the basis of disease the autoimmune disease diagnostics market is categorized into seven segments namely: Graves’ disease, Hashimotos’s thyroiditis, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, systemic lupus erythematosus and others. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, autoimmune disease diagnostics market has been segmented into four major regions: North America, Europe, Asia-Pacific, and Rest of the World. The market size and forecast for each of these regions has been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global autoimmune disease diagnostics market.

A list of recommendations has been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the autoimmune disease diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Abbott Laboratories, Inc., Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Bio- Rad laboratories, bioMerieux SA, Siemens Healthcare, Inova Diagnostics Inc., Quest Diagnostics and SQL Diagnostics, Inc.

The global autoimmune disease diagnostics market is segmented as follows:

Global Autoimmune Disease Diagnostics Market, by Test Type

  • Antinuclear Antibody Tests
  • Autoantibody Tests
  • Complete Blood Count (CBC)
  • Comprehensive Metabolic Panel
  • C - reactive protein (CRP)
  • Erythrocyte Sedimentation Rate (ESR)
  • Urinalysis
  • Others

 

Global Autoimmune Disease Diagnostics Market, by Disease Type

  • Graves' Disease
  • Hashimoto's Thyroiditis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus (lupus)
  • Type 1 diabetes
  • Others

Global Autoimmune Disease Diagnostics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East
    • Africa